↓ Skip to main content

Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study

Overview of attention for article published in Reproductive Biology and Endocrinology, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
7 tweeters
wikipedia
2 Wikipedia pages
video
2 video uploaders

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study
Published in
Reproductive Biology and Endocrinology, January 2012
DOI 10.1186/1477-7827-10-52
Pubmed ID
Authors

Franco Lisi, Piero Carfagna, Mario Oliva, Rocco Rago, Rosella Lisi, Roberta Poverini, Claudio Manna, Elena Vaquero, Donatella Caserta, Valeria Raparelli, Roberto Marci, Massimo Moscarini

Abstract

Aim of this pilot study is to examine the effects of myo-inositol administration on ovarian response and oocytes and embryos quality in non PolyCystic Ovary Syndrome (PCOS) patients undergoing multiple follicular stimulation and in vitro insemination by conventional in vitro fertilization or by intracytoplasmic sperm injection.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Other 14 18%
Researcher 14 18%
Student > Bachelor 9 12%
Student > Master 7 9%
Student > Postgraduate 6 8%
Other 18 23%
Unknown 9 12%
Readers by discipline Count As %
Medicine and Dentistry 32 42%
Agricultural and Biological Sciences 10 13%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Biochemistry, Genetics and Molecular Biology 6 8%
Nursing and Health Professions 6 8%
Other 3 4%
Unknown 13 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2022.
All research outputs
#1,636,117
of 22,797,621 outputs
Outputs from Reproductive Biology and Endocrinology
#67
of 973 outputs
Outputs of similar age
#12,266
of 244,426 outputs
Outputs of similar age from Reproductive Biology and Endocrinology
#3
of 33 outputs
Altmetric has tracked 22,797,621 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 973 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.9. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,426 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.